SEP 11, 2018 9:42 PM PDT

Widely-Used Drug Contributed To Skin Cancer

WRITTEN BY: Nouran Amin

Credit:  MIT

In a research study at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute, a drug, by the name of azathioprine, which is used to treat inflammatory bowel disease (IBD), arthritis and vasculitis as well as preventing organ rejection in transplant patients, has been identified as a contributor the development of skin cancer.

Published in Nature Communications, the research identified a `strong case for an association' between azathioprine and a mutation found in a common form of skin cancer known as cutaneous squamous cell carcinoma (cSCC). Previously, it was known that azathioprine leads to a heightened photosensitivity to UVA light. Such sensitivity is believed to be the key behind its contribution to skin cancers. The study found that the use of azathioprine leaves a ‘molecular fingerprint’ in skin cancers, implicating it in cSCC. "We recommend all physicians give appropriate advice on UVA avoidance including year-round sun protection for their patients on azathioprine,” explains Professor of Dermatology--Charlotte Proby in the School of Medicine at Dundee.

Credit: Ctdermgroup.com

However, the research team is not necessarily promoting the withdrawal of azathioprine. "As with all medications the risks must be balanced against the benefits, particularly with the need to treat potentially life-threatening diseases with an effective drug," explains Proby. “It is important that sun protection, skin surveillance and early diagnosis/lesion removal are part of the routine management of patients on azathioprine."

cSCC is a commonly diagnosed skin cancer. "It's important to protect your skin from the sun when it's strong, especially if you burn easily or are taking medications which make you more sun-sensitive. The most effective protection is to spend time in the shade and cover up with a hat, long-sleeved top, and sunglasses. For the bits you can't cover, use sunscreen with at least 4 stars and SPF 15 or higher for protection against both UVA and UVB rays,” says Sarah Lowes of Cancer Research UK.

The research also revealed the molecular nature of cSCC which highlighted the potential targets that may be developed for future treatments.

Source: University of Dundee, Nature Communications

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 26, 2020
Cardiology
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
NOV 26, 2020
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
Cardiovascular disease and diabetes are often associated with each other, as many issues caused by diabetes promote hear ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
Loading Comments...